查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
2024187

全球临床实验室服务市场：策略与趋势，包括按检测类型、地点、产品和国家分類的预测—高阶主管和顾问的指导性情境分析（2026-2030 年）—第 9 版

Global Clinical Medical Laboratory Services Market. Strategy & Trends with Forecasts by Assay Type, by Place, by Product, and by Country. Situation Analysis with Executive & Consultant Guides - 9th Edition. 2026 to 2030
出版日期: | 出版商: Howe Sound Research | 英文 385 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

报告摘要：

临床实验室服务是现代医学的基础组成部分，提供用于疾病检测、治疗方案製定和患者健康监测的诊断资讯。临床实验室支持多种疾病的诊疗，包括心血管疾病、糖尿病、感染疾病、传染病、自体免疫、肾臟疾病和代谢性疾病。临床实验室服务涵盖广泛的检测类别，包括临床化学、血液学、免疫检测、微生物学、分子诊断、基因检测、毒理学和组织病理学。

全球临床实验室服务市场预计到 2025 年将达到 2,031 亿美元，并预计以 8.8% 的复合年增长率成长，到 2030 年达到 3,102 亿美元。这一增长是由人口老化、慢性病患病率上升、医疗保健服务覆盖范围扩大以及对预防医学和疾病早期检测的日益重视等人口趋势所驱动的。

临床实验室检测在医疗决策中发挥着至关重要的作用。临床检测结果常用于确诊、评估疾病进展、评估治疗效果、监测病人安全。随着医疗体係日益重视实证医学，对临床实验室服务的需求也持续成长。

临床实验室服务范围

我们的临床检测服务涵盖多种检测类别。

临床化学检测透过测量血液和其他体液中生物标记的浓度来评估器官功能和代谢状态。例如，血糖检测、血脂检测、肝功能检测、肾功能检测和电解质测定等。

血液学检查评估血球和凝血参数。血液常规检查（CBC）是临床上最常进行的检查之一。

免疫检测利用抗原-抗体结合反应来检测蛋白质、荷尔蒙、抗体和其他分析物。免疫检测广泛应用于内分泌学、传染病检查和癌症生物标记分析。

微生物检测采用培养法、抗原检测法和分子技术来检测细菌、病毒、真菌和寄生虫等病原体。

分子诊断技术能够透过检测与疾病相关的核酸序列，以高灵敏度检测感染疾病和遗传异常。

基因检测评估与疾病风险和治疗反应相关的基因变异。

组织病理学是检查组织检体以诊断癌症和其他疾病的领域。

毒理学检测可以检测出毒品、环境毒素和其他物质。

市场结构

临床实验室服务由各种机构提供，包括医院检查室、独立实验室、诊所检查室、大学医院和公共卫生实验室。

医院检查室进行各项检测，以支持住院和门诊病人的临床治疗。许多医院也向诊所和其他医疗机构提供推广检测服务。

独立实验室通常会收到来自众多医疗保健机构的大量检测请求，并运作集中式检测设施，由物流网路支援检体运输。

诊所内检查室在诊所内进行常规检测。

公共卫生检查室进行与疾病监测和集体爆发监测相关的检测。

在许多情况下，检测实验室提供广泛的检测项目和专业的检测能力。

检测网路通常运作多个检测设施，以确保地理覆盖范围并优化报告检测结果所需的时间。

市场驱动因素

推动临床实验室服务市场成长的因素有很多。

随着人口老化，糖尿病、心血管疾病和癌症等慢性疾病的盛行率不断上升，导致对诊断测试的需求增加。

预防性医疗保健服务的日益普及，也带动了对常规临床检测的需求。

随着个人化医疗的扩展，分子诊断和基因检测等专业临床检测的使用正在增加。

随着慢性病盛行率的增加，对持续病患监测的需求也日益增长。

诊断技术的进步使得开发新的临床检测方法成为可能。

新兴市场医疗保健服务的改善促进了检测数量的增加。

临床指引越来越推荐使用临床检测来进行疾病管理。

许多地区扩大医疗保险覆盖范围，提高了获得临床实验室服务的机会。

科技趋势

技术创新提高了临床检查室的效率，并扩大了它们可以进行的检测范围。

检体处理和分析工作流程的自动化提高了处理能力，并缩短了报告结果的时间。

分子诊断技术正在扩大可透过临床检测诊断的疾病范围。

数位病理技术实现了组织检体的远端分析，加强了病理学家之间的合作。

实验室资讯系统改善了实验室数据的管理及其与电子健康记录的整合。

即时检测技术正在扩大传统检查室环境以外的诊断检测途径。

人工智慧工具正在被开发出来，以辅助解读诊断结果。

自动化减少了人工操作流程，提高了可重复性。

机器人技术和先进设备的整合提高了检查室效率。

市场区隔

临床实验室服务市场可以按检测类型、服务提供者、最终用户和地区进行细分。

按检测类型划分，临床化学和血液学检测占据了检测量最大的部分。由于精准医疗方法的日益普及，分子诊断和基因检测正迅速成为成长最快的领域。

按服务供应商，医院检查室和独立实验室构成主要部分。

最终使用者包括医院、诊所、门诊部和公共卫生组织。

由于北美地区医疗费用支出高、诊断基础设施先进，因此是最大的区域市场。

欧洲拥有完善的医疗保健体系，是重要的市场。

由于对医疗基础设施的投资增加，亚太市场正在扩张。

在新兴市场，随着诊断服务可近性的提高，潜在的成长机会正在涌现。

竞争格局

临床实验室服务市场包括大规模全国性检测网路、区域实验室、医院检查室和专业诊断服务供应商。

竞争的驱动因素包括价格、检测结果报告时间、地理覆盖范围以及可用检测的广度。

大规模测试网路可以受益于规模经济和集中式测试设施。

检测实验室与医疗保健提供者之间的策略伙伴关係可以影响市场份额。

整合先进的诊断技术可以提供竞争优势。

选择检测实验室时，服务品质和可靠性是重要的考虑因素。

物流能力在检体运输中扮演至关重要的角色。

检测实验室正加大对数位基础设施和自动化技术的投资。

未来展望

随着诊断检测需求的成长，临床实验室服务市场预计将继续扩张。

分子诊断和基因检测的发展可能会扩大检测服务在个人化医疗中的作用。

自动化技术可以提高效率，并有可能降低每次检测的成本。

扩大即时检测范围可作为集中检测服务的补充。

人工智慧（AI）工具可以提高对测试数据的解读能力。

人口健康管理措施可能会导致预防医学中检测手段的增加。

总体而言，临床实验室服务是医疗保健服务的重要组成部分。诊断技术、自动化和数据分析的不断进步有望支撑市场长期稳定成长。

目录

第一章 市集指南

  • 战略态势分析
    • 在医疗保健服务中的作用
    • 价格压力和赎回限制
    • 市场整合与竞争格局
    • 劳动力短缺和营运挑战
    • 技术创新与数位转型
    • 分子和基因检测的扩展
    • 监管和品质要求
    • 物流和样品管理方面的挑战
    • 地理市场动态
    • 展望与战略意义
  • 企业主管、行销负责人、销售负责人和业务拓展负责人。
  • 管理顾问和投资顾问指南
  • 人工智慧的影响

第二章：引言与市场定义

  • 对临床试验的新需求
  • 机会的定义
  • 调查方法
  • 展望：医疗保健和体外诊断产业

第三章：动态市场概述

  • 参与企业充满活力的市场
    • 学术研究办公室
    • 诊断测试开发人员
    • 测量仪器供应商
    • 化学品/试剂供应商
    • 病理检测用品供应商
    • 独立临床实验室
    • 国家/地区公共研究机构
    • 医院检查室
    • 医师诊所检查室(POLS)
    • 审计机构
    • 认证机构
  • 细分——多种方法
  • 临床检测产业的结构
  • 国家和地区的多样性

第四章：推动市场变化的趋势

  • 成长的驱动力来自多个方面。
  • 导致市场萎缩的因素
  • 自动化和实验室的发展趋势

第五章：临床实验室服务的最新趋势

第六章：主要企业概况

  • Accel Diagnostics
  • Acibadem Labmed Laboratory
  • ACM Medical Laboratory
  • Adicon Clinical Laboratories
  • Aegis Science Corporation
  • American Bio-Clinical Laboratories, Int'l
  • ARUP Laboratories
  • Ascend Clinical
  • Bio-Reference Laboratories
  • Bioscientia Institut fur Medizinische Diagnostik GmbH
  • BP Healthcare Group
  • C2N Diagnostics
  • Clinical Reference Laboratory
  • Clongen Laboratories
  • CompuNet Clinical Laboratories
  • DASA
  • DIAN Diagnostics Co., Ltd.
  • Enzo Biochem
  • Eone Laboratories
  • Eurofins Scientific
  • Exagen Diagnostics
  • Flow Health
  • Fyr Diagnostics
  • Genzyme Corporation
  • Guangzhou Kingmed Diagnostics Group Co., Ltd.
  • Haystack Oncology（Quest Dx）
  • Innoquest Pathology
  • Integrated Regional Laboratories
  • KDL Group
  • Laboratory Corporation of America
  • Lifelabs（Quest）
  • Mayo Clinic Laboratories
  • Medicover
  • Myriad Genetics
  • NeoGenomics
  • OncoDNA
  • Oncohost
  • Prometheus Laboratories
  • ProPhase Labs
  • Psychemedics Corporation
  • Quest Diagnostics
  • SkylineDx
  • Sonic Healthcare
  • Sophia Genetics
  • Spectra Laboratories
  • Streamline Scientific
  • Synlab
  • -Sysmex Inostics
  • Unilabs
  • Werfen

第七章：全球临床检测市场

  • 全球市场概览（按国家/地区划分）
  • 全球市场概览（按检测类型划分）
  • 全球市场概览（按地区划分）
  • 全球市场概览（按产品划分）

第八章 全球临床实验室诊断市场－依检测类型划分

  • 化学
  • 微生物学
  • 血液学
  • 解剖病理学
  • 分子诊断
  • 神秘测试

第九章 全球临床实验室诊断市场－按地区划分

  • 住院医院
  • 门诊病人医院
  • 独立研究机构
  • 临床检查室
  • 其他的

第十章：全球临床实验室诊断市场－依产品划分

  • 装置
  • 试剂
  • 人事费用
  • 间接费用
  • 其他的

第十一章：临床检查室的未来

第十二章附录

表格一览

图表清单

简介目录
Product Code: CLIN 426

Report Overview:

Clinical laboratory testing services represent a foundational component of modern healthcare, providing diagnostic information used to detect disease, guide treatment decisions, and monitor patient health. Laboratory testing supports management of a wide range of medical conditions including cardiovascular disease, diabetes, cancer, infectious diseases, autoimmune disorders, kidney disease, and metabolic conditions. Clinical laboratory services include a broad array of test categories such as clinical chemistry, hematology, immunoassays, microbiology, molecular diagnostics, genetic testing, toxicology, and anatomic pathology.

The global Clinical Laboratory Testing Services market is estimated to be USD 203.1 billion in 2025 and is expected to grow at compound annual growth rates of 8.8% through to 2030 when it will reach USD 310.2 Billion. Growth is driven by demographic trends including aging populations, increasing prevalence of chronic diseases, expanding access to healthcare services, and growing emphasis on preventive medicine and early disease detection.

Laboratory testing plays an important role in healthcare decision-making. Clinical laboratory results are frequently used to confirm diagnoses, evaluate disease progression, assess treatment effectiveness, and monitor patient safety. As healthcare systems increasingly emphasize evidence-based medicine, demand for laboratory testing services continues to increase.

Scope of Laboratory Testing Services

Clinical laboratory services encompass a wide range of testing categories.

Clinical chemistry tests measure levels of biomarkers in blood and other body fluids to evaluate organ function and metabolic health. Examples include glucose testing, lipid panels, liver function tests, kidney function tests, and electrolyte measurements.

Hematology tests evaluate blood cells and coagulation parameters. Complete blood count (CBC) tests represent one of the most commonly ordered laboratory tests.

Immunoassays detect proteins, hormones, antibodies, and other analytes using antigen-antibody binding reactions. Immunoassay testing is widely used in endocrinology, infectious disease testing, and cancer biomarker analysis.

Microbiology testing detects bacterial, viral, fungal, and parasitic pathogens using culture methods, antigen detection, and molecular techniques.

Molecular diagnostics detect nucleic acid sequences associated with disease, enabling highly sensitive detection of infectious diseases and genetic abnormalities.

Genetic testing evaluates inherited variations associated with disease risk or treatment response.

Anatomic pathology involves examination of tissue samples to diagnose cancer and other diseases.

Toxicology testing detects drugs, environmental toxins, and other substances.

Market Structure

Clinical laboratory testing services are delivered through multiple types of providers including hospital-based laboratories, independent reference laboratories, physician office laboratories, academic medical centers, and public health laboratories.

Hospital laboratories perform testing to support inpatient and outpatient clinical care. Many hospitals also provide outreach testing services to physician offices and other healthcare providers.

Independent reference laboratories perform large volumes of testing from multiple healthcare providers and often operate centralized testing facilities supported by logistics networks for specimen transport.

Physician office laboratories perform routine tests within medical practices.

Public health laboratories perform testing related to disease surveillance and outbreak monitoring.

Reference laboratories often offer extensive test menus and specialized testing capabilities.

Laboratory networks often operate multiple testing facilities to support geographic coverage and optimize turnaround time.

Market Drivers

Several factors are driving growth in the clinical laboratory testing services market.

Aging populations are increasing demand for diagnostic testing due to higher prevalence of chronic diseases such as diabetes, cardiovascular disease, and cancer.

Increasing use of preventive healthcare services is supporting demand for routine laboratory testing.

Expansion of personalized medicine is increasing use of specialized laboratory tests such as molecular diagnostics and genetic testing.

Growth in chronic disease prevalence is increasing demand for ongoing patient monitoring.

Advances in diagnostic technologies are enabling development of new laboratory tests.

Increased healthcare access in emerging markets is supporting growth in testing volumes.

Clinical guidelines increasingly recommend laboratory testing for disease management.

Expansion of health insurance coverage in many regions supports access to laboratory services.

Technology Trends

Technological innovation is improving efficiency and expanding test menus within clinical laboratories.

Automation of sample processing and analytical workflows is improving throughput and reducing turnaround time.

Molecular diagnostics technologies are expanding the range of conditions that can be diagnosed using laboratory testing.

Digital pathology technologies enable remote analysis of tissue samples and improved collaboration among pathologists.

Laboratory information systems improve management of test data and integration with electronic health records.

Point-of-care testing technologies are expanding access to diagnostic testing outside traditional laboratory settings.

Artificial intelligence tools are being developed to assist interpretation of diagnostic results.

Automation is reducing manual processing steps and improving reproducibility.

Integration of robotics and advanced instrumentation is improving laboratory efficiency.

Market Segmentation

The clinical laboratory testing services market can be segmented by test type, service provider, end user, and geographic region.

By test type, clinical chemistry and hematology represent high-volume segments. Molecular diagnostics and genetic testing represent rapidly growing segments due to increasing use of precision medicine approaches.

By service provider, hospital laboratories and independent reference laboratories represent major segments.

End users include hospitals, physician offices, outpatient clinics, and public health agencies.

North America represents the largest regional market due to high healthcare spending and advanced diagnostic infrastructure.

Europe represents a significant market supported by established healthcare systems.

Asia-Pacific markets are expanding due to increasing investment in healthcare infrastructure.

Emerging markets represent potential growth opportunities as access to diagnostic services improves.

Competitive Landscape

The clinical laboratory testing services market includes large national laboratory networks, regional laboratories, hospital laboratories, and specialized diagnostic service providers.

Competition is influenced by pricing, turnaround time, geographic coverage, and breadth of test menu.

Large laboratory networks may benefit from economies of scale and centralized testing facilities.

Strategic partnerships between laboratories and healthcare providers may influence market share.

Integration of advanced diagnostic technologies may provide competitive advantages.

Service quality and reliability are important factors in laboratory selection.

Logistics capabilities play an important role in specimen transport.

Laboratories are increasingly investing in digital infrastructure and automation technologies.

Future Outlook

The clinical laboratory testing services market is expected to continue expanding as demand for diagnostic testing increases.

Growth in molecular diagnostics and genetic testing may expand the role of laboratory services in personalized medicine.

Automation technologies may improve efficiency and reduce cost per test.

Expansion of point-of-care testing may complement centralized laboratory services.

Artificial intelligence tools may improve interpretation of laboratory data.

Population health management initiatives may increase use of laboratory testing for preventive care.

Overall, clinical laboratory testing services represent a critical component of healthcare delivery. Continued advances in diagnostic technologies, automation, and data analytics are expected to support steady long-term market growth.

Table of Contents

1 Market Guides

  • 1.1 Strategic Situation Analysis
    • 1.1.1 Role in Healthcare Delivery
    • 1.1.2 Pricing Pressure and Reimbursement Constraints
    • 1.1.3 Market Consolidation and Competitive Landscape
    • 1.1.4 Workforce Shortages and Operational Challenges
    • 1.1.5 Technological Innovation and Digital Transformation
    • 1.1.6 Expansion of Molecular and Genetic Testing
    • 1.1.7 Regulatory and Quality Requirements
    • 1.1.8 Logistics and Sample Management Challenges
    • 1.1.9 Geographic Market Dynamics
    • 1.1.10 Outlook and Strategic Implications
  • 1.2 Guide for Executives, Marketing, Sales and Business Development Staff
  • 1.3 Guide for Management Consultants and Investment Advisors
  • 1.4 Impact of Artificial Intelligence

2 Introduction and Market Definition

  • 2.1 The New Demand for Clinical Testing
  • 2.2 Defining the Opportunity
    • 2.2.1 Revenue Market Size
  • 2.3 Methodology
    • 2.3.1 Methodology
    • 2.3.2 Sources
    • 2.3.3 Authors
  • 2.4 Perspective: Healthcare and the IVD Industry
    • 2.4.1 Global Healthcare Spending
    • 2.4.2 Spending on Diagnostics
    • 2.4.3 Important Role of Insurance for Diagnostics

3 Overview of a Dynamic Market

  • 3.1 Players in a Dynamic Market
    • 3.1.1 Academic Research Lab
    • 3.1.2 Diagnostic Test Developer
    • 3.1.3 Instrumentation Supplier
    • 3.1.4 Chemical/Reagent Supplier
    • 3.1.5 Pathology Supplier
    • 3.1.6 Independent Clinical Laboratory
    • 3.1.7 Public National/regional Laboratory
    • 3.1.8 Hospital Laboratory
    • 3.1.9 Physicians Office Lab (POLS)
    • 3.1.10 Audit Body
    • 3.1.11 Certification Body
  • 3.2 Segmentation - Different Approaches
    • 3.2.1 Traditional Market Segmentation
    • 3.2.2 Laboratory Focus and Segmentation
  • 3.3 Structure of Clinical Testing Industry
    • 3.3.1 The Hospital Lab - Share of the Pie
    • 3.3.2 Key Role for Economies of Scale
    • 3.3.3 Physician Office Lab's are Still Here
    • 3.3.4 Physician's and POCT - Reviving Patient Service in China
  • 3.4 National and Regional Diversity

4 Trends Driving a Changing Market

  • 4.1 Growth Is Pushed from Many Sides
    • 4.1.1 Demographic Impacts on Consumption
    • 4.1.2 COVID Related Impacts
    • 4.1.3 Point of Care Testing Makes a Difference
    • 4.1.4 Alternative Medicine Effect
    • 4.1.5 Esoterics
    • 4.1.6 A New Laboratory Discipline
  • 4.2 Factors at Work to Shrink the Market
    • 4.2.1 Where are Costs Going?
    • 4.2.2 Population Effects
    • 4.2.3 Management Practices
    • 4.2.4 Wellness
    • 4.2.5 Cannabilization
    • 4.2.6 Point of Care
  • 4.3 Automation and Laboratory Trends
    • 4.3.1 Traditional Automation and Centralization
    • 4.3.2 The New Automation, Decentralization and Point Of Care
    • 4.3.3 Instruments Key to Market Share
    • 4.3.4 Bioinformatics Plays a Role
    • 4.3.5 PCR Takes Command
    • 4.3.6 Next Generation Sequencing Fuels a Revolution
    • 4.3.7 NGS Impact on Pricing
    • 4.3.8 Whole Genome Sequencing, A Brave New World
    • 4.3.9 Companion Diagnostics Blurs Diagnosis and Treatment
    • 4.3.10 Shifting Role of Diagnostics

5 Clinical Laboratory Services Recent Developments

  • 5.1 Recent Developments - Importance and How to Use This Section
    • 5.1.1 Importance of These Developments
    • 5.1.2 How to Use This Section
  • 5.2 Source Bioscience Acquires Cambridge Clinical Labs
  • 5.3 Labcorp Acquires Select Assets of BioReference Health
  • 5.4 hc1 + Accumen Launches Clinical Excellence Solutions
  • 5.5 Labcorp enters lab management, services agreement with Inspira Health
  • 5.6 Aventa Genomics Receives Favorable Pricing Determination
  • 5.7 Perseus Completes Acquisition of Matrix Sistemas e Servicos Ltda
  • 5.8 Delve Bio Announces Partnership with Broad Clinical Labs for mNGS
  • 5.9 Quest Dx to Acquire Select Lab Assets from Allina Health
  • 5.10 Eurofins buys Ascend Clinical LLC
  • 5.11 Atalan Sees Potential in Hospital Outreach Business
  • 5.12 Challenge Bringing Routine Testing to Point of Care
  • 5.13 Natera Cites Test Volume Growth, Rosy Reimbursement
  • 5.14 Patients Becoming Stakeholders in Infectious Disease Testing
  • 5.15 MedGenome Acquires Prognosis Laboratories
  • 5.16 Brooks Automation acquires Aim Lab
  • 5.17 Avalon GloboCare Announces Strategic Investment in Laboratory Services MSO
  • 5.18 Mayo Clinic Laboratories and Helix to provide Biopharma Services
  • 5.19 CompuGroup Medical acquires Medicus Laboratory Information Systems
  • 5.20 Quest Diagnostics acquires Summa Health outreach lab
  • 5.21 Q2 Solutions Launches Self-Collection Safety Lab Panel
  • 5.22 Bionano Genomics Announces Launch of Bionano Laboratories
  • 5.23 Labcorp to Spin Off Clinical Development Business
  • 5.24 Value-Based Care Growing More Profitable for Labs
  • 5.25 Lucid Diagnostics Reports Revenue Growth
  • 5.26 NGS Cancer Testing Decision Appeases Industry
  • 5.27 Clinical Labs Make Strong Showing in 2021
  • 5.28 Seegene to Enter Syndromic MDx Space
  • 5.29 EKF Diagnostics Acquires Advanced Diagnostic Laboratory
  • 5.30 Molecular Health, EDGC Ink Liquid Biopsy Partnership
  • 5.31 ProPhase Labs Acquires Nebula Genomics for $14.6M
  • 5.32 Karius Cell-Free DNA Method to Detect Infection Validated
  • 5.33 EDGC Enters Liquid Biopsy Space With Cf DNA
  • 5.34 TruDiagnostic Receives CLIA Certification for Kentucky Laboratory
  • 5.35 Enzo Biochem Q2 Revenues Up 62 Percent
  • 5.36 Thermo Fisher Gets CE Mark for High-Throughput COVID-19 Assay
  • 5.37 FDA Issues Alert - False Negatives due to SARS-CoV-2 Mutations
  • 5.38 Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19?
  • 5.39 Chinese Infectious Dx Firm Vision Medicals Completes Series B Financing
  • 5.40 Cooperative Aims to Expand Clinical, Commercial NGS Access

6 Profiles of Key Companies

  • 6.1 Accel Diagnostics
  • 6.2 Acibadem Labmed Laboratory
  • 6.3 ACM Medical Laboratory
  • 6.4 Adicon Clinical Laboratories
  • 6.5 Aegis Science Corporation
  • 6.6 American Bio-Clinical Laboratories, Int'l
  • 6.7 ARUP Laboratories
  • 6.8 Ascend Clinical
  • 6.9 Bio-Reference Laboratories
  • 6.10 Bioscientia Institut fur Medizinische Diagnostik GmbH
  • 6.11 BP Healthcare Group
  • 6.12 C2N Diagnostics
  • 6.13 Clinical Reference Laboratory
  • 6.14 Clongen Laboratories
  • 6.15 CompuNet Clinical Laboratories
  • 6.16 DASA
  • 6.17 DIAN Diagnostics Co., Ltd.
  • 6.18 Enzo Biochem
  • 6.19 Eone Laboratories
  • 6.20 Eurofins Scientific
  • 6.21 Exagen Diagnostics
  • 6.22 Flow Health
  • 6.23 Fyr Diagnostics
  • 6.24 Genzyme Corporation
  • 6.25 Guangzhou Kingmed Diagnostics Group Co., Ltd.
  • 6.26 Haystack Oncology (Quest Dx)
  • 6.27 Innoquest Pathology
  • 6.28 Integrated Regional Laboratories
  • 6.29 KDL Group
  • 6.30 Laboratory Corporation of America
  • 6.31 Lifelabs (Quest)
  • 6.32 Mayo Clinic Laboratories
  • 6.33 Medicover
  • 6.34 Myriad Genetics
  • 6.35 NeoGenomics
  • 6.36 OncoDNA
  • 6.37 Oncohost
  • 6.38 Prometheus Laboratories
  • 6.39 ProPhase Labs
  • 6.40 Psychemedics Corporation
  • 6.41 Quest Diagnostics
  • 6.42 SkylineDx
  • 6.43 Sonic Healthcare
  • 6.44 Sophia Genetics
  • 6.45 Spectra Laboratories
  • 6.46 Streamline Scientific
  • 6.47 Synlab
  • 6.48 -Sysmex Inostics
  • 6.49 Unilabs
  • 6.50 Werfen

7 The Global Market for Clinical Laboratory Testing

  • 7.1 Global Market Overview by Country
    • 7.1.1 Table - Global Market by Country
    • 7.1.2 Chart - Global Market by Country
  • 7.2 Global Market by Assay Type - Overview
    • 7.2.1 Table - Global Market by Assay Type
    • 7.2.2 Chart - Global Market by Assay Type - Base/Final Year Comparison
    • 7.2.3 Chart - Global Market by Assay Type - Base Year
    • 7.2.4 Chart - Global Market by Assay Type - End Year
    • 7.2.5 Chart - Global Market by Assay Type - Share by Year
    • 7.2.6 Chart - Global Market by Assay Type - Segments Growth
  • 7.3 Global Market by Place - Overview
    • 7.3.1 Table - Global Market by Place
    • 7.3.2 Chart - Global Market by Place - Base/Final Year Comparison
    • 7.3.3 Chart - Global Market by Place - Base Year
    • 7.3.4 Chart - Global Market by Place - End Year
    • 7.3.5 Chart - Global Market by Place - Share by Year
    • 7.3.6 Chart - Global Market by Place - Segments Growth
  • 7.4 Global Market by Product - Overview
    • 7.4.1 Table - Global Market by Product
    • 7.4.2 Chart - Global Market by Product - Base/Final Year Comparison
    • 7.4.3 Chart - Global Market by Product - Base Year
    • 7.4.4 Chart - Global Market by Product - End Year
    • 7.4.5 Chart - Global Market by Product - Share by Year
    • 7.4.6 Chart - Global Market by Product - Segments Growth

8 Global Clinical Laboratory Diagnostic Markets - By Assay Type

  • 8.1 Chemistry
    • 8.1.1 Table Chemistry - by Country
    • 8.1.2 Chart - Chemistry Growth
  • 8.2 Microbiology
    • 8.2.1 Table Microbiology - by Country
    • 8.2.2 Chart - Microbiology Growth
  • 8.3 Hematology
    • 8.3.1 Table Hematology - by Country
    • 8.3.2 Chart - Hematology Growth
  • 8.4 Anatomic Pathology
    • 8.4.1 Table Anatomic Pathology - by Country
    • 8.4.2 Chart - Anatomic Pathology Growth
  • 8.5 Molecular Diagnostics
    • 8.5.1 Table Molecular Diagnostics - by Country
    • 8.5.2 Chart - Molecular Diagnostics Growth
  • 8.6 Esoteric
    • 8.6.1 Table Esoteric - by Country
    • 8.6.2 Chart - Esoteric Growth

9 Global Clinical Laboratory Diagnostic Markets - By Place

  • 9.1 In Patient Hospital
    • 9.1.1 Table In Patient Hospital - by Country
    • 9.1.2 Chart - In Patient Hospital Growth
  • 9.2 Out Patient Hospital
    • 9.2.1 Table Out Patient Hospital - by Country
    • 9.2.2 Chart - Out Patient Hospital Growth
  • 9.3 Independent Laboratory
    • 9.3.1 Table Independent Laboratory - by Country
    • 9.3.2 Chart - Independent Laboratory Growth
  • 9.4 Physicians Office Laboratory
    • 9.4.1 Table Physicians Office Laboratory - by Country
    • 9.4.2 Chart - Physicians Office Laboratory Growth
  • 9.5 Other Laboratory
    • 9.5.1 Table Other Laboratory - by Country
    • 9.5.2 Chart - Other Laboratory Growth

10 Global Clinical Laboratory Diagnostic Markets - By Product

  • 10.1 Instruments
    • 10.1.1 Table Instruments - by Country
    • 10.1.2 Chart - Instruments Growth
  • 10.2 Reagents
    • 10.2.1 Table Reagents - by Country
    • 10.2.2 Chart - Reagents Growth
  • 10.3 Labour
    • 10.3.1 Table Labour - by Country
    • 10.3.2 Chart - Labour Growth
  • 10.4 Overhead
    • 10.4.1 Table Overhead - by Country
    • 10.4.2 Chart - Overhead Growth
  • 10.5 Other Product
    • 10.5.1 Table Other Product - by Country
    • 10.5.2 Chart - Other Product Growth

11 The Future of the Clinical Laboratory

12 Appendices

  • 12.1 United States Medicare System: Clinical Laboratory Fees Schedule
  • 12.2 The Most Used IVD Assays
  • 12.3 The Highest Grossing Assays

Table of Tables

  • Table 1 Market Players by Type
  • Table 2 Clinical Laboratory Departments and Segments
  • Table 3 Laboratory Management Focus - Different Approaches
  • Table 4 Key Segmentation Variables Going Forward
  • Table 5 Factors Affecting Local Clinical Testing Demand
  • Table 6 Seven Factors Driving Growth
  • Table 7 Alternative Medicine Segments
  • Table 8 Six Factors Limiting Growth
  • Table 9 Seven Key Diagnostic Laboratory Technology Trends
  • Table 10 - Global Market by Region
  • Table 11 Global Market by Assay Type
  • Table 12 Global Market by Place
  • Table 13 Global Market by Product
  • Table 14 Chemistry by Country
  • Table 15 Microbiology by Country
  • Table 16 Hematology by Country
  • Table 17 Anatomic Pathology by Country
  • Table 18 Molecular Diagnostics by Country
  • Table 19 Esoteric by Country
  • Table 20 In Patient Hospital by Country
  • Table 21 Out Patient Hospital by Country
  • Table 22 Independent Laboratory by Country
  • Table 23 Physicians Office Laboratory by Country
  • Table 24 Other Laboratory by Country
  • Table 25 Instruments by Country
  • Table 26 Reagents by Country
  • Table 27 Labour by Country
  • Table 28 Overhead by Country
  • Table 29 Other Product by Country
  • Table 30 Clinical Lab Fee Schedule
  • Table 31 The Most Common Assays
  • Table 32 Largest Revenue Assays

Table of Figures

  • Figure 1 Global Healthcare Spending
  • Figure 2 The Road to Diagnostics
  • Figure 3 The Changing Age of The World's Population
  • Figure 4 Health Care Consumption by Age
  • Figure 5 Cancer Incidence - Age at Diagnosis
  • Figure 6 Centralized vs. Decentralized Laboratory Service
  • Figure 7 A Highly Multiplexed Syndromic Testing Unit
  • Figure 8 The Real Cost to Sequence the Human Genome
  • Figure 9 The Codevelopment Process
  • Figure 10 Comparing MDx Diagnostic and Traditional Testing
  • Figure 11 Global Market Pareto Chart
  • Figure 12 Global Market by Assay Type - Base vs. Final
  • Figure 13 Global Market by Assay Type Base Year
  • Figure 14 Global Market by Assay Type End Year
  • Figure 15 Assay Type Share by Year
  • Figure 16 Assay Type Segments Growth
  • Figure 17 Global Market by Place - Base vs. Final
  • Figure 18 Global Market by Place Base Year
  • Figure 19 Global Market by Place End Year
  • Figure 20 Place Share by Year
  • Figure 21 Place Segments Growth
  • Figure 22 Global Market by Product - Base vs. Final
  • Figure 23 Global Market by Product Base Year
  • Figure 24 Global Market by Product End Year
  • Figure 25 Product Share by Year
  • Figure 26 Product Segments Growth
  • Figure 27 Chemistry Growth
  • Figure 28 Microbiology Growth
  • Figure 29 Hematology Growth
  • Figure 30 Anatomic Pathology Growth
  • Figure 31 Molecular Diagnostics Growth
  • Figure 32 Esoteric Growth
  • Figure 33 In Patient Hospital Growth
  • Figure 34 Out Patient Hospital Growth
  • Figure 35 Independent Laboratory Growth
  • Figure 36 Physicians Office Laboratory Growth
  • Figure 37 Other Laboratory Growth
  • Figure 38 Instruments Growth
  • Figure 39 Reagents Growth
  • Figure 40 Labour Growth
  • Figure 41 Overhead Growth
  • Figure 42 Other Product Growth